Impact of P2Y12 inhibitor pretreatment on periprocedural (type 4a) myocardial infarction and bleeding in NSTEMI

In NSTEMI patients undergoing PCI, pretreatment with P2Y<sub>12</sub> inhibitors, mainly clopidogrel, did not reduce the incidence of type 4a MI but was associated with an increased risk of in-hospital bleeding.

Authors

Institutions

Publication Details

Journal
Revista Española de Cardiología (English Edition)
Published
2025-12-01
DOI
https://doi.org/10.1016/j.rec.2025.12.002
Citations
1
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of P2Y12 inhibitor pretreatment on periprocedural (type 4a) myocardial infarction and bleeding in NSTEMI

Francesca Bodega, Daniele Cavallo, Carmine Pizzi, Marco Valgimigli et al.
1 citations
Revista Española de Cardiología (English Edition)
Antiplatelet Therapy and Cardiovascular Diseases
1.39
article

Impact of P2Y12 inhibitor pretreatment on periprocedural (type 4a) myocardial infarction and bleeding in NSTEMI

Francesca Bodega, Daniele Cavallo, Carmine Pizzi, Marco Valgimigli, Alberto Foà, Milena Leo, Andrea Rinaldi, Elio Fabbri, Sara Amicone, Angelo Sansonetti, Khrystyna Ryabenko, Gianni Casella, Matteo Armillotta, Francesco Angeli, Francesco Saia, Pasquale Paolisso, Damiano Fedele, Ornella Di Iuorio, Paola Rucci, Lisa Canton, Nicolò Vasumini, Marta Belmonte, Marco Basile, Luca Bergamaschi, Angelo Maida, Francesco Pio Tattilo, Tommaso Manaresi
article en
1 citations

Abstract

In NSTEMI patients undergoing PCI, pretreatment with P2Y<sub>12</sub> inhibitors, mainly clopidogrel, did not reduce the incidence of type 4a MI but was associated with an increased risk of in-hospital bleeding.

Revista Española de Cardiología (English Edition)
Ospedale Maggiore (IT), Ente Ospedaliero Cantonale (CH), Ospedale Maggiore Carlo Alberto Pizzardi (IT), Azienda USL di Bologna (IT), Azienda Ospedaliera Sant'Andrea (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Bologna (IT)
Openalex Percentile: Top 13%
Antiplatelet Therapy and Cardiovascular Diseases
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.